VTRS - Big pharma rally after J&J earnings
2024-07-17 14:09:20 ET
More on AbbVie, Bristol-Myers, etc.
- Is Bristol-Myers Squibb's Rich Dividend Yield Worth The Patent Cliff Correction Risk?
- Johnson & Johnson (JNJ) Q2 2024 Earnings Call Transcript
- Don't Let The Market Fool You: Bristol-Myers Is Not A Value Trap
- J&J beats in Q2 as pharma segment outperforms
- Johnson & Johnson declares $1.24 dividend